FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Cruise Ship Returns to Texas Port Shortly After Departure When Murder Victim Is Discovered On Board

Multiple Kennedy family members seek to join legal battle against Trump’s triumphal arch

10 Serial Killers Among Those Whose Sentences Were Commuted by Gavin Newsom

‘He blamed the Jews’: GOP congressman levels explosive accusation against JD Vance over election postmortem

Russia and Ukraine settle on large prisoner swap after no major developments from talks

Secretary Scott Bessent moved to military base over Iran threats and more top headlines

Slain New Jersey mom’s bedroom furniture removed by investigators months after unsolved stabbing

FIRST ON FOX: Supreme Court justices confront what it will take to keep America’s founding freedoms alive

Senate Republicans plan 54-day blitz to push Trump’s agenda before Democrats seize power

Did the blue wave leave Gavin Newsom behind?

South Yemeni leaders to US: Cut your losses in Yemen and support an independent south

UN denies working with Hamas-loving Gaza ‘aid’ group funded by American Marxist

NYC man accused of 3 Central Park rapes arrested at Miami Burger King

Multiple dead after vehicle crashes into food stand near North Hollywood Metro station

Mullin vows ‘zero change’ on immigration after Republicans suffer crushing midterm losses

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”